Molecular Diagnostics Point of Care Market
完整報告名稱與涵蓋範圍
Molecular Diagnostics Point of Care Market Size, Share & Trends Analysis Report By Test Location (Over-the-Counter (OTC), PoC), By Technology (PCR-based, Genetic Sequencing-based, Hybridization-based, Microarray-based), By Application, By End-Use, By Region, And By Segment Forecasts, 2024-2031
報告摘要
The Molecular Diagnostics Point of Care Market on a global scale was estimated at USD 2.95 Billion in 2023 and is set to attain USD 6.42 Billion by 2031, with a projected CAGR of 10.38% between 2024 and 2031.
Molecular Diagnostics Point of Care covers key industry insights & findings from the report:
The advent of the molecular diagnostic poc market represents a paradigm shift in healthcare accessibility, driving efficiency and quality of care imp. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Several factors contribute to this trajectory, including heightened requirement next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Molecular Diagnostics Point of Care Market Snapshot
Chapter 4. Global Molecular Diagnostics Point of Care Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Test Location Estimates & Trend Analysis
5.1. by Test Location & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Test Location:
5.2.1. Over-the-Counter (OTC)
5.2.2. PoC
Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis
6.1. by Technology & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology:
6.2.1. PCR-based
6.2.2. Genetic Sequencing-based
6.2.3. Hybridization-based
6.2.4. Microarray-based
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
7.2.1. Infectious Diseases
7.2.2. Oncology
7.2.3. Hematology
7.2.4. Prenatal Testing
7.2.5. Endocrinology
7.2.6. Others
Chapter 8. Market Segmentation 4: by End-use Estimates & Trend Analysis
8.1. by End-use & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-use:
8.2.1. Decentralized Labs
8.2.2. Hospitals
8.2.3. Homecare
8.2.4. Assisted Living Healthcare Facilities
8.2.5. Others
Chapter 9. Molecular Diagnostics Point of Care Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Molecular Diagnostics Point of Care Market Revenue (US$ Million) Estimates and Forecasts by Test Location, 2024-2031
9.1.2. North America Molecular Diagnostics Point of Care Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.1.3. North America Molecular Diagnostics Point of Care Market revenue (US$ Million) by Application, 2024-2031
9.1.4. North America Molecular Diagnostics Point of Care Market revenue (US$ Million) by End-use, 2024-2031
9.1.5. North America Molecular Diagnostics Point of Care Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Molecular Diagnostics Point of Care Market revenue (US$ Million) by Test Location, 2024-2031
9.2.2. Europe Molecular Diagnostics Point of Care Market revenue (US$ Million) by Technology, 2024-2031
9.2.3. Europe Molecular Diagnostics Point of Care Market revenue (US$ Million) by Application, 2024-2031
9.2.4. Europe Molecular Diagnostics Point of Care Market revenue (US$ Million) by End-use, 2024-2031
9.2.5. Europe Molecular Diagnostics Point of Care Market revenue (US$ Million) by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Molecular Diagnostics Point of Care Market revenue (US$ Million) by Test Location, 2024-2031
9.3.2. Asia Pacific Molecular Diagnostics Point of Care Market revenue (US$ Million) by Technology, 2024-2031
9.3.3. Asia-Pacific Molecular Diagnostics Point of Care Market revenue (US$ Million) by Application, 2024-2031
9.3.4. Asia-Pacific Molecular Diagnostics Point of Care Market revenue (US$ Million) by End-use, 2024-2031
9.3.5. Asia Pacific Molecular Diagnostics Point of Care Market revenue (US$ Million) by country, 2024-2031
9.4. Latin America
9.4.1. Latin America Molecular Diagnostics Point of Care Market revenue (US$ Million) by Test Location, 2024-2031
9.4.2. Latin America Molecular Diagnostics Point of Care Market revenue (US$ Million) by Technology, 2024-2031
9.4.3. Latin America Molecular Diagnostics Point of Care Market revenue (US$ Million) by Application, 2024-2031
9.4.4. Latin America Molecular Diagnostics Point of Care Market revenue (US$ Million) by End-use, 2024-2031
9.4.5. Latin America Molecular Diagnostics Point of Care Market revenue (US$ Million) by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Molecular Diagnostics Point of Care Market revenue (US$ Million) by Test Location, 2024-2031
9.5.2. Middle East & Africa Molecular Diagnostics Point of Care Market revenue (US$ Million) by Technology, 2024-2031
9.5.3. Middle East & Africa Molecular Diagnostics Point of Care Market revenue (US$ Million) by Application, 2024-2031
9.5.4. Middle East & Africa Molecular Diagnostics Point of Care Market revenue (US$ Million) by End-use, 2024-2031
9.5.5. Middle East & Africa Molecular Diagnostics Point of Care Market revenue (US$ Million) by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.2. Bayer Healthcare
10.2.3. Roche Diagnostics
10.2.4. Bio-Rad Laboratories
10.2.5. Danaher Corporation
10.2.6. BioMerieux
10.2.7. Dako
10.2.8. Abaxis Inc.
10.2.9. OraSure Technologies Inc.
10.2.10. Nipro Diagnostics
10.2.11. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們